|4Feb 3, 7:39 PM ET

LUSMAN JOEL 4

4 · AUTOIMMUNE INC · Filed Feb 3, 2009

Insider Transaction Report

Form 4
Period: 2009-02-03
Transactions
  • Purchase

    Common Stock, par value $0.01

    2009-01-30$0.89/sh+109,500$97,6962,646,500 total(indirect: Footnote)
  • Purchase

    Common Stock, par value $0.01

    2009-02-03$1.08/sh+1,000$1,0802,655,000 total(indirect: Footnote)
  • Purchase

    Common Stock, par value $0.01

    2009-02-02$0.93/sh+7,500$6,9502,654,000 total(indirect: Footnote)
Footnotes (1)
  • [F1]Mr. Lusman is the sole managing member of Lusman Capital Management, LLC and Lusman Capital GP, LLC. In accordance with the foregoing, Lusman Capital Management, LLC, Lusman Capital GP, LLC and Mr. Lusman may be deemed to beneficially own the securities of the Issuer owned by the various entities managed by Lusman Capital Management, LLC and Lusman Capital GP, LLC respectively. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Documents

1 file
  • 4
    p961384_ex.xmlPrimary